CL2013001251A1 - Process for preparing naltrexone comprising reacting noroxymorphone with cyclopropylmethyl halide in the presence of n-ethyl-2-pyrrolidone; process for preparing nalmaphene comprising manufacturing naltrexone and processing it further from for nalmafen through the wittig reaction; naltrexone; and nalmaphene. - Google Patents
Process for preparing naltrexone comprising reacting noroxymorphone with cyclopropylmethyl halide in the presence of n-ethyl-2-pyrrolidone; process for preparing nalmaphene comprising manufacturing naltrexone and processing it further from for nalmafen through the wittig reaction; naltrexone; and nalmaphene.Info
- Publication number
- CL2013001251A1 CL2013001251A1 CL2013001251A CL2013001251A CL2013001251A1 CL 2013001251 A1 CL2013001251 A1 CL 2013001251A1 CL 2013001251 A CL2013001251 A CL 2013001251A CL 2013001251 A CL2013001251 A CL 2013001251A CL 2013001251 A1 CL2013001251 A1 CL 2013001251A1
- Authority
- CL
- Chile
- Prior art keywords
- naltrexone
- nalmaphene
- preparing
- nalmafen
- pyrrolidone
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
- C07D489/08—Oxygen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA201001007 | 2010-11-05 | ||
DKPA201100396 | 2011-05-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2013001251A1 true CL2013001251A1 (en) | 2013-08-30 |
Family
ID=46552826
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2013001251A CL2013001251A1 (en) | 2010-11-05 | 2013-05-06 | Process for preparing naltrexone comprising reacting noroxymorphone with cyclopropylmethyl halide in the presence of n-ethyl-2-pyrrolidone; process for preparing nalmaphene comprising manufacturing naltrexone and processing it further from for nalmafen through the wittig reaction; naltrexone; and nalmaphene. |
Country Status (12)
Country | Link |
---|---|
KR (1) | KR101837795B1 (en) |
CN (1) | CN103237804B (en) |
AR (1) | AR087142A1 (en) |
BR (1) | BR112013009407B8 (en) |
CL (1) | CL2013001251A1 (en) |
CO (1) | CO6700868A2 (en) |
IL (1) | IL225790A (en) |
JO (1) | JO3209B1 (en) |
PE (2) | PE20171309A1 (en) |
SG (1) | SG189369A1 (en) |
TW (1) | TWI516491B (en) |
ZA (1) | ZA201303224B (en) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2129395T3 (en) * | 1989-10-16 | 1999-06-16 | Us Health | TOTAL SYNTHESIS OF NORTEBAINE, NORMORPHINE, NOROXYMORPHONE ENANTIOMERS AND THEIR DERIVATIVES THROUGH N-NOR INTERMEDIATE PRODUCTS. |
UA87884C2 (en) * | 2004-12-03 | 2009-08-25 | Мерк Энд Ко., Инк. | Potassium salt of an hiv integrase inhibitor |
FR2906252B1 (en) * | 2006-09-21 | 2008-11-28 | Sanofi Aventis Sa | PROCESS FOR THE PREPARATION OF NALTREXONE N-AKLYL HALIDES |
WO2008138383A1 (en) * | 2007-05-16 | 2008-11-20 | Cilag Ag | Method for the production of n-methyl naltrexone bromide |
US8080661B2 (en) * | 2008-09-30 | 2011-12-20 | Mallinckrodt Llc | Processes for the synthesis of tertiary amines |
-
2011
- 2011-10-31 JO JOP/2011/0328A patent/JO3209B1/en active
- 2011-11-01 TW TW100139692A patent/TWI516491B/en not_active IP Right Cessation
- 2011-11-03 AR ARP110104090A patent/AR087142A1/en unknown
- 2011-11-04 PE PE2017001285A patent/PE20171309A1/en not_active Application Discontinuation
- 2011-11-04 CN CN201180053349.6A patent/CN103237804B/en active Active
- 2011-11-04 KR KR1020137011320A patent/KR101837795B1/en active IP Right Grant
- 2011-11-04 BR BR112013009407A patent/BR112013009407B8/en active IP Right Grant
- 2011-11-04 PE PE2013000948A patent/PE20140357A1/en not_active Application Discontinuation
- 2011-11-04 SG SG2013027412A patent/SG189369A1/en unknown
-
2013
- 2013-04-17 IL IL225790A patent/IL225790A/en active IP Right Grant
- 2013-05-03 ZA ZA2013/03224A patent/ZA201303224B/en unknown
- 2013-05-03 CO CO13111250A patent/CO6700868A2/en active IP Right Grant
- 2013-05-06 CL CL2013001251A patent/CL2013001251A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
TW201219396A (en) | 2012-05-16 |
PE20171309A1 (en) | 2017-09-05 |
KR20130129928A (en) | 2013-11-29 |
BR112013009407A2 (en) | 2016-07-19 |
BR112013009407B1 (en) | 2021-07-20 |
AR087142A1 (en) | 2014-02-26 |
JO3209B1 (en) | 2018-03-08 |
KR101837795B1 (en) | 2018-03-12 |
ZA201303224B (en) | 2014-07-30 |
TWI516491B (en) | 2016-01-11 |
BR112013009407B8 (en) | 2022-11-22 |
CN103237804A (en) | 2013-08-07 |
IL225790A0 (en) | 2013-06-27 |
PE20140357A1 (en) | 2014-03-29 |
SG189369A1 (en) | 2013-05-31 |
IL225790A (en) | 2016-07-31 |
CO6700868A2 (en) | 2013-06-28 |
CN103237804B (en) | 2016-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2596430A4 (en) | A system and method for the parallel execution of database queries over cpus and multi core processors | |
EP2554717A4 (en) | Die, process for producing die, and process for producing antireflection film | |
PL2835242T3 (en) | Method, device and a computer program for manufacturing a pre-insulated skeleton framing segment | |
BR112013000288A2 (en) | process for the production of articles formed from cellulose | |
PL2576628T3 (en) | Process for producing microcellulose | |
BR112012009974A2 (en) | method for producing granules comprising a perticide | |
BRPI1007791A2 (en) | Method for the extraction of methane from methane hydrates | |
BR112013013407A8 (en) | process for producing one or more alcohols from gaseous substrate | |
BR112013008883A2 (en) | process for the manufacture of dihydropteridinones | |
PL2512777T3 (en) | Process for producing a curved substrate covered with a film | |
EP2632957A4 (en) | Process for the derivatization of cellulose | |
BR112013009492A2 (en) | process for the production of lipids from biomass | |
AP2013006897A0 (en) | Method for the manufacturing of naltrexone | |
EP2641889A4 (en) | Methanol production process | |
TWI563595B (en) | Method for producing chip stacks as well as a carrier for executing the method | |
EG27075A (en) | A urea stripping process for the production of urea | |
EP2616505A4 (en) | Process for producing melamine-formaldehyde foams | |
CL2014001454A1 (en) | Process for recovering nalmefene hydrochloride from an aqueous composition containing nalmefene and naltrexone hydrochloride, which comprises the step of isolating nalmefene hcl from an aqueous suspension comprising adduct of naltrexone bisulfite and solid nalmefene hcl. | |
PL2561047T3 (en) | Process for manufacturing pellets | |
BRPI1011020A2 (en) | process for producing granules from powder materials | |
BRPI1010218A2 (en) | modified polyamide, preparation process, article obtained from that polyamide | |
CL2013001251A1 (en) | Process for preparing naltrexone comprising reacting noroxymorphone with cyclopropylmethyl halide in the presence of n-ethyl-2-pyrrolidone; process for preparing nalmaphene comprising manufacturing naltrexone and processing it further from for nalmafen through the wittig reaction; naltrexone; and nalmaphene. | |
EP2522648A4 (en) | Process for producing difluorocyclopropane compound | |
BRPI1012305A2 (en) | chemical process for the production of haloalkenone ethers | |
BR112012002613A2 (en) | process for the preparation of chlorine. |